BEAT Stock: Price, Forecast, Financials & AI Analysis

High

Open

VWAP

Vol

Mkt Cap

Low

Amount

EV/EBITDA(TTM)

Total Shares

EV/OCF(TTM)

P/S(TTM)

Market Estimates

Earnings Estimates

Revenue

YoY Chg

EPS

YoYChg

FY2025Q4

FY2026Q1

FY2026Q2

-0.137

-24.07%

-0.133

-25.93%

-0.137

-8.89%

Estimates Revision

The market is revising No Change the revenue expectations for HeartBeam, Inc. (BEAT) for FY2025, with the revenue forecasts being adjusted by 0% over the past three months. During the same period, the stock price has changed by 86.52%.

Revenue Estimates for FY2025

No Change

0.00%

In Past 3 Month

EPS Estimates for FY2025

Revise Downward

-0.79%

In Past 3 Month

Stock Price

Go Up

+86.52%

In Past 3 Month

2 Analyst Rating

Wall Street analysts forecast BEAT stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for BEAT is 6.00 USD with a low forecast of 4.00 USD and a high forecast of 8.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

2 Buy

0 Hold

0 Sell

Moderate Buy

Current: 2.630

Low

4.00

Averages

6.00

High

8.00

Current: 2.630

Low

4.00

Averages

6.00

High

8.00

Roth Capital

NULL -> Buy

initiated

2025-10-31

Reason

Roth Capital

Price Target

2025-10-31

initiated

NULL -> Buy

Reason

Roth Capital initiated coverage of HeartBeam with a Buy rating and $4 price target. The company is developing a credit-card-sized, cable-free cardiac device that synthesizes a 12-lead electrocardiogram, the analyst tells investors in a research note. The firm expects FDA clearance in the "coming days" that will initially focus on advanced cardiac arrhythmias within the concierge medicine market.

Valuation Metrics

The current forward P/E ratio for Heartbeam Inc (BEAT.O) is -4.76, compared to its 5-year average forward P/E of -2.78. For a more detailed relative valuation and DCF analysis to assess Heartbeam Inc 's fair value, click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

N/A

5Y Average PE

-2.78

Current PE

-4.76

Overvalued PE

-1.45

Undervalued PE

-4.11

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

N/A

5Y Average EV/EBITDA

-0.10

Current EV/EBITDA

0.00

Overvalued EV/EBITDA

0.34

Undervalued EV/EBITDA

-0.54

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

N/A

5Y Average PS

86.93

Current PS

0.00

Overvalued PS

373.19

Undervalued PS

-199.33

Financials

Annual

Quarterly

N/A

Operating Profit

N/A

Net Income after Tax

N/A

EPS - Diluted

N/A

Free Cash Flow

Trading Trends

Insider

Insiders are Neutral. There are no significant trading trends over the last month.

Sold

Bought

Hedge Fund

Hedge Funds are Neutral. There are no significant trading trends over the last quarter.

Sold

Bought

Congress Trading

Congress are Neutral. There are no significant trading trends over the last month.

Sold

Bought

Insider

Insiders are Neutral. There are no significant trading trends over the last month.

Sold

Bought

BEAT News & Events

Events Timeline

No data

News

9.0

12-11NASDAQ.COM

BEAT Receives FDA Approval for First Wireless At-Home 12-Lead ECG Device

7.5

12-11Benzinga

"Investors Focus on Oracle, Synopsys, Heartbeam, Planet Labs, and Adobe: Key Reasons Behind the Interest"

2.0

12-10Benzinga

What’s Driving the Surge in Micro Cap HeartBeam Stock This Wednesday?

People Also Watch

Frequently Asked Questions

What is Heartbeam Inc (BEAT) stock price today?

The current price of BEAT is 2.63 USD — it has increased 14.35 % in the last trading day.

What is Heartbeam Inc (BEAT)'s business?

HeartBeam, Inc. is a cardiac technology company. The Company focuses on developing and commercializing higher resolution ambulatory Electrocardiogram (ECG) solutions that enable the detection and monitoring of cardiac disease both inside and outside a healthcare facility setting. It is engaged in the development of higher resolution ECG solutions is achieved through the development of the Company’s proprietary and patented electrocardiography technology platform. It is developing three-dimensional (3D) representations of cardiac electrical activity by displaying the spatial locations of ECG waveforms. It is developing its own product, the HeartBeam System. The HeartBeam System comprises a credit card sized 12-lead output electrocardiogram device, a patient application, a physician portal, and powerful cloud-based algorithms. The core technology consists of a series of patented inventions that allow it to capture the heart’s electrical activity from three distinct directions.

What is the price predicton of BEAT Stock?

What is Heartbeam Inc (BEAT)'s revenue for the last quarter?

Heartbeam Inc revenue for the last quarter amounts to -5.29M USD, increased 4.36 % YoY.

What is Heartbeam Inc (BEAT)'s earnings per share (EPS) for the last quarter?

Heartbeam Inc. EPS for the last quarter amounts to -3242000.00 USD, decreased -4.90 % YoY.

What changes have occurred in the market's expectations for Heartbeam Inc (BEAT)'s fundamentals?

How many employees does Heartbeam Inc (BEAT). have?

Heartbeam Inc (BEAT) has 21 emplpoyees as of December 16 2025.

What is Heartbeam Inc (BEAT) market cap?

Today BEAT has the market capitalization of 90.59M USD.